FindMyKOL
Clinical trialNCT00892333CompletedObservational

Large Abdominal Hernia Repair With SurgiMend 3.0

SponsorIntegra LifeSciences CorporationEnrollment122Hernia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The rate of hernia recurrence at one year following repair of a large abdominal hernia with a biologic mesh is high, ranging from 30% to 100%, with a reported historic average rate of 40%. The purpose of this study is to evaluate the rate of hernia recurrence at one year following repair with SurgiMend 3.0, an FDA-cleared novel biologic mesh, the hypothesis being that such rate will be less than 20% at one year, representing a 50% reduction over the historic rate of 40%.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • George C Velmahos, MD, Ph.D.

    Massachusetts General Hospital/ Harvard University

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Los Angeles County/university of Southern California Medical Center

    Los Angeles, California, United States

  • Yale University School of Medicine

    New Haven, Connecticut, United States

  • Cook County Hospital

    Chicago, Illinois, United States

  • Boston Medical Center

    Boston, Massachusetts, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • State University of New York (suny), Upstate Medical Center

    Syracuse, New York, United States

  • Oklahoma University

    Oklahoma City, Oklahoma, United States

  • Oregon Health and Science University (ohsu)

    Portland, Oregon, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2009
Primary completion
31 Jul 2014
Completion
31 Jul 2014
Last update posted
17 May 2016
Registered enrollment
122
Registry id
NCT00892333

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.